Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
Contact Us
Versions and log file
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
ZOLEDRONIC ACID
(2001)
Small molecule
Farnesyl diphosphate synthase inhibitor
INJECTION; INTRAVENOUS; IV (INFUSION)
Approved
Bone Diseases; Multiple Myeloma; Neoplasm Metastasis; Osteitis Deformans; Osteoporosis; Osteoporosis, Postmenopausal; Prostatic Neoplasms
ZOLEDRONIC ACID
×
Maximum Phase:
4
First Approval:
2001
UNII:
70HZ18PH24
Molecule Type:
Small molecule
Molecular Formula:
C5H10N2O7P2
Molecular Weight:
272.09
AlogP:
-1.12
PSA:
153.11
HBD:
5.0
HBA:
#RotB:
4.0
Source:
ZIPRASIDONE
(2001)
Small molecule
Unknown
Unknown
Approved
Psychotic Disorders
ZIPRASIDONE
×
Maximum Phase:
4
First Approval:
2001
UNII:
6UKA5VEJ6X
Molecule Type:
Small molecule
Molecular Formula:
C21H21ClN4OS
Molecular Weight:
412.95
AlogP:
3.81
PSA:
48.47
HBD:
1.0
HBA:
#RotB:
4.0
Source:
VALGANCICLOVIR
(2001)
Small molecule
Unknown
Unknown
Approved
Virus Diseases
VALGANCICLOVIR
×
Maximum Phase:
4
First Approval:
2001
UNII:
GCU97FKN3R
Molecule Type:
Small molecule
Molecular Formula:
C14H22N6O5
Molecular Weight:
354.37
AlogP:
-1.44
PSA:
171.37
HBD:
4.0
HBA:
#RotB:
8.0
Source:
CASPOFUNGIN ACETATE
(2001)
Small molecule
1,3-beta-glucan synthase inhibitor
INTRAVENOUS
Approved
Aspergillosis; Candidemia; Candidiasis; Mycoses
CASPOFUNGIN ACETATE
×
Maximum Phase:
4
First Approval:
2001
UNII:
VUW370O5QE
Molecule Type:
Small molecule
Molecular Formula:
C56H96N10O19
Molecular Weight:
1213.43
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
NORELGESTROMIN
(2001)
Small molecule
Progesterone receptor agonist
Unknown
Approved
Unknown
NORELGESTROMIN
×
Maximum Phase:
4
First Approval:
2001
UNII:
R0TAY3X631
Molecule Type:
Small molecule
Molecular Formula:
C21H29NO2
Molecular Weight:
327.47
AlogP:
4.14
PSA:
52.82
HBD:
2.0
HBA:
#RotB:
1.0
Source:
ZIPRASIDONE HYDROCHLORIDE
(2001)
Small molecule
Dopamine D2 receptor antagonist
ORAL
Approved
Arrhythmias, Cardiac; Bipolar Disorder; Mental Disorders; Schizophrenia; Tachycardia, Ventricular
ZIPRASIDONE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2001
UNII:
216X081ORU
Molecule Type:
Small molecule
Molecular Formula:
C21H24Cl2N4O2S
Molecular Weight:
467.42
AlogP:
3.81
PSA:
48.47
HBD:
1.0
HBA:
#RotB:
4.0
Source:
TENOFOVIR DISOPROXIL FUMARATE
(2001)
Small molecule
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
ORAL
Approved
HIV Infections; Hepatitis B, Chronic; Infections; Liver Diseases
TENOFOVIR DISOPROXIL FUMARATE
×
Maximum Phase:
4
First Approval:
2001
UNII:
OTT9J7900I
Molecule Type:
Small molecule
Molecular Formula:
C23H34N5O14P
Molecular Weight:
635.52
AlogP:
3.04
PSA:
185.44
HBD:
1.0
HBA:
#RotB:
13.0
Source:
ETHINYL ESTRADIOL
(2001)
Small molecule
Estrogen receptor alpha agonist
ORAL
Approved
Acne Vulgaris; Neoplasms
ETHINYL ESTRADIOL
×
Maximum Phase:
4
First Approval:
2001
UNII:
423D2T571U
Molecule Type:
Small molecule
Molecular Formula:
C20H24O2
Molecular Weight:
296.41
AlogP:
3.61
PSA:
40.46
HBD:
2.0
HBA:
#RotB:
0.0
Source:
FROVATRIPTAN
(2001)
Small molecule
Unknown
Unknown
Approved
Migraine Disorders
FROVATRIPTAN
×
Maximum Phase:
4
First Approval:
2001
UNII:
H82Q2D5WA7
Molecule Type:
Small molecule
Molecular Formula:
C14H17N3O
Molecular Weight:
243.31
AlogP:
1.34
PSA:
70.91
HBD:
3.0
HBA:
#RotB:
2.0
Source:
FORMOTEROL
(2001)
Small molecule
Unknown
Unknown
Approved
Lung Diseases, Obstructive
FORMOTEROL
×
Maximum Phase:
4
First Approval:
2001
UNII:
5ZZ84GCW8B
Molecule Type:
Small molecule
Molecular Formula:
C19H24N2O4
Molecular Weight:
344.41
AlogP:
2.22
PSA:
90.82
HBD:
4.0
HBA:
#RotB:
9.0
Source:
FORMOTEROL FUMARATE
(2001)
Small molecule
Beta-2 adrenergic receptor agonist
INHALATION
Approved
Asthma; Bronchial Spasm; Bronchitis, Chronic; Emphysema; Pulmonary Disease, Chronic Obstructive
FORMOTEROL FUMARATE
×
Maximum Phase:
4
First Approval:
2001
UNII:
W34SHF8J2K
Molecule Type:
Small molecule
Molecular Formula:
C42H56N4O14
Molecular Weight:
840.92
AlogP:
2.22
PSA:
90.82
HBD:
4.0
HBA:
#RotB:
9.0
Source:
ERTAPENEM SODIUM
(2001)
Small molecule
Bacterial penicillin-binding protein inhibitor
INTRAMUSCULAR; INTRAVENOUS
Approved
Infections; Intraabdominal Infections; Osteomyelitis
ERTAPENEM SODIUM
×
Maximum Phase:
4
First Approval:
2001
UNII:
2T90KE67L0
Molecule Type:
Small molecule
Molecular Formula:
C22H24N3NaO7S
Molecular Weight:
497.51
AlogP:
0.94
PSA:
156.27
HBD:
5.0
HBA:
#RotB:
7.0
Source:
TENOFOVIR DISOPROXIL
(2001)
Small molecule
Unknown
Unknown
Approved
Virus Diseases
TENOFOVIR DISOPROXIL
×
Maximum Phase:
4
First Approval:
2001
UNII:
F4YU4LON7I
Molecule Type:
Small molecule
Molecular Formula:
C19H30N5O10P
Molecular Weight:
519.45
AlogP:
3.04
PSA:
185.44
HBD:
1.0
HBA:
#RotB:
13.0
Source:
VALGANCICLOVIR HYDROCHLORIDE
(2001)
Small molecule
Human herpesvirus 1 DNA polymerase inhibitor
ORAL
Approved
Acquired Immunodeficiency Syndrome; Cytomegalovirus Retinitis; Retinitis
VALGANCICLOVIR HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2001
UNII:
4P3T9QF9NZ
Molecule Type:
Small molecule
Molecular Formula:
C14H23ClN6O5
Molecular Weight:
390.83
AlogP:
-1.44
PSA:
171.37
HBD:
4.0
HBA:
#RotB:
8.0
Source:
GALANTAMINE
(2001)
Small molecule
Unknown
Unknown
Approved
Dementia
GALANTAMINE
×
Maximum Phase:
4
First Approval:
2001
UNII:
1T835Z585R
Molecule Type:
Small molecule
Molecular Formula:
C17H21NO3
Molecular Weight:
287.36
AlogP:
1.85
PSA:
41.93
HBD:
1.0
HBA:
#RotB:
1.0
Source:
ALMOTRIPTAN MALATE
(2001)
Small molecule
Serotonin 1b (5-HT1b) receptor agonist
ORAL
Approved
Migraine Disorders
ALMOTRIPTAN MALATE
×
Maximum Phase:
4
First Approval:
2001
UNII:
PJP312605E
Molecule Type:
Small molecule
Molecular Formula:
C21H31N3O7S
Molecular Weight:
469.56
AlogP:
2.2
PSA:
56.41
HBD:
1.0
HBA:
#RotB:
6.0
Source:
ALMOTRIPTAN
(2001)
Small molecule
Unknown
Unknown
Approved
Migraine Disorders
ALMOTRIPTAN
×
Maximum Phase:
4
First Approval:
2001
UNII:
1O4XL5SN61
Molecule Type:
Small molecule
Molecular Formula:
C17H25N3O2S
Molecular Weight:
335.47
AlogP:
2.2
PSA:
56.41
HBD:
1.0
HBA:
#RotB:
6.0
Source:
DESLORATADINE
(2001)
Small molecule
Histamine H1 receptor antagonist
ORAL
Approved
Hypersensitivity; Rhinitis, Allergic, Seasonal; Urticaria
DESLORATADINE
×
Maximum Phase:
4
First Approval:
2001
UNII:
FVF865388R
Molecule Type:
Small molecule
Molecular Formula:
C19H19ClN2
Molecular Weight:
310.83
AlogP:
4.02
PSA:
24.92
HBD:
1.0
HBA:
#RotB:
0.0
Source:
VALDECOXIB
(2001)
Small molecule
Cyclooxygenase-2 inhibitor
ORAL
Approved
Rheumatic Diseases
VALDECOXIB
×
Maximum Phase:
4
First Approval:
2001
UNII:
2919279Q3W
Molecule Type:
Small molecule
Molecular Formula:
C16H14N2O3S
Molecular Weight:
314.37
AlogP:
2.96
PSA:
86.19
HBD:
1.0
HBA:
#RotB:
3.0
Source:
IMATINIB
(2001)
Small molecule
Unknown
Unknown
Approved
Neoplasms
IMATINIB
×
Maximum Phase:
4
First Approval:
2001
UNII:
BKJ8M8G5HI
Molecule Type:
Small molecule
Molecular Formula:
C29H31N7O
Molecular Weight:
493.62
AlogP:
4.59
PSA:
86.28
HBD:
2.0
HBA:
#RotB:
7.0
Source:
DUTASTERIDE
(2001)
Small molecule
Steroid 5-alpha-reductase inhibitor
ORAL
Approved
Prostatic Hyperplasia; Prostatic Neoplasms
DUTASTERIDE
×
Maximum Phase:
4
First Approval:
2001
UNII:
O0J6XJN02I
Molecule Type:
Small molecule
Molecular Formula:
C27H30F6N2O2
Molecular Weight:
528.54
AlogP:
6.58
PSA:
58.2
HBD:
2.0
HBA:
#RotB:
2.0
Source:
CEFDITOREN PIVOXIL
(2001)
Small molecule
Bacterial penicillin-binding protein inhibitor
ORAL
Approved
Bronchitis, Chronic; Infections; Pharyngitis; Tonsillitis
CEFDITOREN PIVOXIL
×
Maximum Phase:
4
First Approval:
2001
UNII:
78THA212DH
Molecule Type:
Small molecule
Molecular Formula:
C25H28N6O7S3
Molecular Weight:
620.74
AlogP:
2.3
PSA:
175.4
HBD:
2.0
HBA:
#RotB:
9.0
Source:
DROSPIRENONE
(2001)
Small molecule
Mineralocorticoid receptor antagonist
ORAL
Approved
Acne Vulgaris
DROSPIRENONE
×
Maximum Phase:
4
First Approval:
2001
UNII:
N295J34A25
Molecule Type:
Small molecule
Molecular Formula:
C24H30O3
Molecular Weight:
366.5
AlogP:
4.31
PSA:
43.37
HBD:
0.0
HBA:
#RotB:
0.0
Source:
BIMATOPROST
(2001)
Small molecule
Prostanoid FP receptor agonist
OPHTHALMIC; TOPICAL
Approved
Glaucoma; Glaucoma, Open-Angle; Hypotrichosis; Ocular Hypertension
BIMATOPROST
×
Maximum Phase:
4
First Approval:
2001
UNII:
QXS94885MZ
Molecule Type:
Small molecule
Molecular Formula:
C25H37NO4
Molecular Weight:
415.57
AlogP:
3.15
PSA:
89.79
HBD:
4.0
HBA:
#RotB:
12.0
Source:
DEXMETHYLPHENIDATE HYDROCHLORIDE
(2001)
Small molecule
Dopamine transporter inhibitor
ORAL
Approved
Attention Deficit Disorder with Hyperactivity
DEXMETHYLPHENIDATE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2001
UNII:
4B3SC438HI
Molecule Type:
Small molecule
Molecular Formula:
C14H20ClNO2
Molecular Weight:
269.77
AlogP:
2.09
PSA:
38.33
HBD:
1.0
HBA:
#RotB:
3.0
Source:
FROVATRIPTAN SUCCINATE
(2001)
Small molecule
Serotonin 1b (5-HT1b) receptor agonist
ORAL
Approved
Migraine Disorders
FROVATRIPTAN SUCCINATE
×
Maximum Phase:
4
First Approval:
2001
UNII:
D28J6W18HY
Molecule Type:
Small molecule
Molecular Formula:
C18H25N3O6
Molecular Weight:
379.41
AlogP:
1.34
PSA:
70.91
HBD:
3.0
HBA:
#RotB:
2.0
Source:
CASPOFUNGIN
(2001)
Small molecule
Unknown
Unknown
Approved
Unknown
CASPOFUNGIN
×
Maximum Phase:
4
First Approval:
2001
UNII:
F0XDI6ZL63
Molecule Type:
Small molecule
Molecular Formula:
C52H88N10O15
Molecular Weight:
1093.33
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
BOSENTAN
(2001)
Small molecule
Endothelin receptor, ET-A/ET-B antagonist
Unknown
Approved
Familial Primary Pulmonary Hypertension; Heart Defects, Congenital; Hypertension; Hypertension, Pulmonary; Pulmonary Arterial Hypertension
BOSENTAN
×
Maximum Phase:
4
First Approval:
2001
UNII:
XUL93R30K2
Molecule Type:
Small molecule
Molecular Formula:
C27H29N5O6S
Molecular Weight:
551.63
AlogP:
4.2
PSA:
145.65
HBD:
2.0
HBA:
#RotB:
10.0
Source:
TOCOPHEROL ACETATE
(2001)
Small molecule
Unknown
Unknown
Approved
Unknown
TOCOPHEROL ACETATE
×
Maximum Phase:
4
First Approval:
2001
UNII:
9E8X80D2L0
Molecule Type:
Small molecule
Molecular Formula:
C31H52O3
Molecular Weight:
472.75
AlogP:
9.06
PSA:
35.53
HBD:
0.0
HBA:
#RotB:
13.0
Source:
IMATINIB MESYLATE
(2001)
Small molecule
Bcr/Abl fusion protein
ORAL
Approved
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
IMATINIB MESYLATE
×
Maximum Phase:
4
First Approval:
2001
UNII:
8A1O1M485B
Molecule Type:
Small molecule
Molecular Formula:
C30H35N7O4S
Molecular Weight:
589.72
AlogP:
4.59
PSA:
86.28
HBD:
2.0
HBA:
#RotB:
7.0
Source:
ESOMEPRAZOLE
(2001)
Small molecule
Unknown
Unknown
Approved
Gastroesophageal Reflux; Peptic Ulcer
ESOMEPRAZOLE
×
Maximum Phase:
4
First Approval:
2001
UNII:
N3PA6559FT
Molecule Type:
Small molecule
Molecular Formula:
C17H19N3O3S
Molecular Weight:
345.42
AlogP:
2.9
PSA:
77.1
HBD:
1.0
HBA:
#RotB:
5.0
Source:
GALANTAMINE HYDROBROMIDE
(2001)
Small molecule
Acetylcholinesterase inhibitor
ORAL
Approved
Alzheimer Disease; Dementia
GALANTAMINE HYDROBROMIDE
×
Maximum Phase:
4
First Approval:
2001
UNII:
5N4SA4KQX9
Molecule Type:
Small molecule
Molecular Formula:
C17H22BrNO3
Molecular Weight:
368.27
AlogP:
1.85
PSA:
41.93
HBD:
1.0
HBA:
#RotB:
1.0
Source:
ETONOGESTREL
(2001)
Small molecule
Progesterone receptor agonist
Unknown
Approved
Unknown
ETONOGESTREL
×
Maximum Phase:
4
First Approval:
2001
UNII:
304GTH6RNH
Molecule Type:
Small molecule
Molecular Formula:
C22H28O2
Molecular Weight:
324.46
AlogP:
4.05
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
1.0
Source:
PIMECROLIMUS
(2001)
Small molecule
FK506-binding protein 1A inhibitor
TOPICAL
Approved
Dermatitis, Atopic; Eczema
PIMECROLIMUS
×
Maximum Phase:
4
First Approval:
2001
UNII:
7KYV510875
Molecule Type:
Small molecule
Molecular Formula:
C43H68ClNO11
Molecular Weight:
810.47
AlogP:
5.72
PSA:
158.13
HBD:
2.0
HBA:
#RotB:
6.0
Source:
PERFLUTREN
(2001)
Small molecule
Diagnostic agent
INTRAVENOUS
Approved
Unknown
PERFLUTREN
×
Maximum Phase:
4
First Approval:
2001
UNII:
CK0N3WH0SR
Molecule Type:
Small molecule
Molecular Formula:
C3F8
Molecular Weight:
188.02
AlogP:
2.75
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
0.0
Source:
TRAVOPROST
(2001)
Small molecule
Prostanoid FP receptor agonist
OPHTHALMIC
Approved
Glaucoma; Glaucoma, Open-Angle; Ocular Hypertension
TRAVOPROST
×
Maximum Phase:
4
First Approval:
2001
UNII:
WJ68R08KX9
Molecule Type:
Small molecule
Molecular Formula:
C26H35F3O6
Molecular Weight:
500.55
AlogP:
4.43
PSA:
96.22
HBD:
3.0
HBA:
#RotB:
12.0
Source:
1
2
…
51
52
53
54
55
56
57
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA